Table-4.
Gene | Expressed tissue/cell | Lactating status and clinical finding (or) treatment^# |
---|---|---|
LAP | MGT* MSC@ | J-H, L-H, L-I, NL-H* HCD diet^ |
TAP | MGT* MEC# | L-H*, S. aureus in vitro challenge# |
DEFB3 | MGT* MSC@ | L-H*, NL-I* |
DEFB4 | MGTθ* MSC@ | L-I*, S. aureus in vivo challengeθ |
DEFB5 | MGTθ* MSC@ | L-I*, S. aureus in vivo challengeθ |
DEFB1 | MGTθ | S. aureus in vivo challengeθ |
DEFB103 | Other than mammary gland** | NA |
Roosen et al., [31],
Lopez-Meza et al., [44],
Bagnicka et al., [53],
Jin et al., [41],
Cormac et al., [50],
Mirabzadeh-Ardakani et al., [59]. TAP=Tracheal antimicrobial peptide, LAP=Lingual antimicrobial peptide, DEFB3=β-defensin 3, DEFB4=β-defensin 4, DEFB5=β-defensin 5, DEFB1=β-defensin 1, DEFB103=β-defensin 103, MGT=Mammary gland tissue, MSC=Milk somatic cells, J=Juvenile, L=Lactating, NL=Non-lactating, H=Healthy, I=Infected, S. aureus=Staphylococcus aureus